Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults

Clinical trial NCT03893669 · COMPLETED

Trial details

NCT number: NCT03893669
Sponsor: SK Chemicals Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prevention of Influenza

Start date: 2012-09-01
Primary completion: 2012-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.